These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16442399)

  • 21. History and development of plant sterol and stanol esters for cholesterol-lowering purposes.
    Thompson GR; Grundy SM
    Am J Cardiol; 2005 Jul; 96(1A):3D-9D. PubMed ID: 15992509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phytosterols dissolved in diacylglycerol oil reinforce the cholesterol-lowering effect of low-dose pravastatin treatment.
    Takeshita M; Katsuragi Y; Kusuhara M; Higashi K; Miyajima E; Mizuno K; Mori K; Obata T; Ohmori R; Ohsuzu F; Onodera Y; Sano J; Sawada S; Tabata S; Tokimitsu I; Tomonobu K; Yamashita T; Yasukawa T; Yonemura A; Nakamura H
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):483-91. PubMed ID: 17964767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of a fenofibrate 145-mg nanoparticle tablet formulation compared with the standard 160-mg tablet in patients with coronary heart disease and dyslipidemia.
    Maciejewski S; Hilleman D
    Pharmacotherapy; 2008 May; 28(5):570-5. PubMed ID: 18447655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
    Geiss HC; Otto C; Parhofer KG
    Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plant sterol or stanol consumption does not affect erythrocyte osmotic fragility in patients on statin treatment.
    de Jong A; Plat J; Mensink RP
    Eur J Clin Nutr; 2006 Aug; 60(8):985-90. PubMed ID: 16482072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phytostanol tablets reduce human LDL-cholesterol.
    McPherson TB; Ostlund RE; Goldberg AC; Bateman JH; Schimmoeller L; Spilburg CA
    J Pharm Pharmacol; 2005 Jul; 57(7):889-96. PubMed ID: 15969949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a stanol-enriched diet on plasma cholesterol and triglycerides in patients treated with statins.
    Castro Cabezas M; de Vries JH; Van Oostrom AJ; Iestra J; van Staveren WA
    J Am Diet Assoc; 2006 Oct; 106(10):1564-9. PubMed ID: 17000189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
    Cubeddu LX; Cubeddu RJ; Heimowitz T; Restrepo B; Lamas GA; Weinberg GB
    Am Heart J; 2006 Nov; 152(5):982.e1-5. PubMed ID: 17070175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.
    Bradford WD; Kleit AN; Nietert PJ; Ornstein S
    Clin Ther; 2006 Dec; 28(12):2105-18; discussion 2104. PubMed ID: 17296467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
    Gazi IF; Daskalopoulou SS; Nair DR; Mikhailidis DP
    Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intensity of lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment among the elderly before and after the 2004 National Cholesterol Education Program Adult Treatment Panel III update.
    Nichols GA; Nag S; Chan W
    Am Heart J; 2007 Sep; 154(3):554-60. PubMed ID: 17719305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of a dietary portfolio diet of cholesterol-lowering foods and a statin on LDL particle size phenotype in hypercholesterolaemic participants.
    Gigleux I; Jenkins DJ; Kendall CW; Marchie A; Faulkner DA; Wong JM; de Souza R; Emam A; Parker TL; Trautwein EA; Lapsley KG; Connelly PW; Lamarche B
    Br J Nutr; 2007 Dec; 98(6):1229-36. PubMed ID: 17663803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Powdered red yeast rice and plant stanols and sterols to lower cholesterol.
    Feuerstein JS; Bjerke WS
    J Diet Suppl; 2012 Jun; 9(2):110-5. PubMed ID: 22531006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examination of encapsulated phytosterol ester supplementation on lipid indices associated with cardiovascular disease.
    Earnest CP; Mikus CR; Lemieux I; Arsenault BJ; Church TS
    Nutrition; 2007 Sep; 23(9):625-33. PubMed ID: 17644340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis.
    Kinlay S
    J Am Coll Cardiol; 2007 May; 49(20):2003-9. PubMed ID: 17512355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
    Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
    Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
    Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.